Catalent VP Of Global Operations Wins Program Director Of The Year Award At Process Excellence Conference




Somerset, N.J. – January 23, 2015 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Sridhar Krishnan, the company’s Vice President of Global Operations, has won the prestigious Program Director of the Year award at the 16th Annual Process Excellence Conference (PEX Week), which took place from 19-21 January, in Orlando, Florida. 

Mr. Krishnan was shortlisted after several rounds of presentations and interviews, conducted over a number of months, by an expert panel of judges from businesses in the UK, US and Italy. His presentations focused on the ways in which Catalent has driven transformation in process excellence over the past 5 years, developing the company’s strategies to enable the culture and mindset of Continuous Improvement, and successfully deploy Lean Six Sigma techniques across the business.

He was presented with the Winner’s Trophy at a ceremony at PEX Week on 20th January.

“We congratulate Sridhar on his well-deserved recognition,” commented Steve Leonard, Senior Vice President, Global Operations, Catalent Pharma Solutions. He added, “I met with leaders from many different industries during PEX Week, ranging from financial services, insurance, electronics and music, to oil and gas and pharmaceuticals and all of these companies are trying to achieve the same goal that Sridhar and we at Catalent are. Namely, to create a competitive advantage by being faster, more agile, more customer focused and by adding value.”

Media Contacts: 
Chris Halling
+44 (0)7580 041073
chris.halling@catalent.com

 Richard Kerns
+44 (0) 161 728 5880
richard@nepr.eu 

 About Catalent

Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,000 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents and in fiscal 2014 generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit www.catalent.com

More products. Better treatments. Reliably supplied.™